Truong Duong, MD
Clinical Cardiac Electrophysiology · Glendale, AZNPI 1922033729
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Boston Scientific at 43.4% of the total. Reporting peaked in 2019 at $23,102 and has fallen 88.8% since, to $2,585 in 2025.
Across 271 payments — averaging $179.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$21K
- Abbott$17K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$5K
- Biotronik Inc.$1K
- Cvrx, Inc.$487
- Johnson & Johnson$416
- plus $3K from 25 others
Across 9 payments — averaging $1835.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$13K
- Cvrx, Inc.$3K
What the payments were for
- Consulting fees$28,74559%
- Speaking & faculty fees$4,5009%
- Travel & lodging$2,0054%
- Food & beverage$13,45128%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 65 | $21,128 |
| Abbott | 68 | $17,481 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 29 | $5,224 |
| Biotronik Inc. | 13 | $1,075 |
| Cvrx, Inc. | 4 | $487 |
| Johnson & Johnson | 19 | $416 |
| Edwards Lifesciences | 3 | $377 |
| Medtronic | 4 | $375 |
| Biosense Webster, Inc. | 5 | $358 |
| Sanofi-aventis U.S. LLC | 18 | $292 |
| Atricure, Inc. | 1 | $181 |
| Boehringer Ingelheim | 8 | $177 |
| E.r. Squibb & Sons, L.L.C. | 4 | $162 |
| Kestra Medical Technology Services, Inc. | 4 | $160 |
| Cleerly, Inc. | 3 | $150 |
| Cardiva Medical, Inc. | 2 | $140 |
| Impulse Dynamics (USA) Inc. | 1 | $122 |
| Amgen | 5 | $71 |
| Inspire Medical Systems, Inc. | 2 | $61 |
| AstraZeneca | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Teleflex LLC | 1 | $28 |
| Exact Sciences | 1 | $23 |
| Pfizer | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $21 |
| Merck | 1 | $21 |
| Novartis | 1 | $21 |
| Baxter Healthcare | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Siemens Medical Solutions USA, Inc. | 1 | $13 |
| Advanced Oxygen Therapy Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$14,818
- Quadra Assura CRT Defibrillator$5,898
- LifeVest$4,500
- Assurity Pacemaker$4,275
- Accent Pacemaker$1,202
- Allure Quadra RF CRT Pacemaker$1,200
- AVEIR$945
- Quadra Allure MP RF CRT Pacemkr$900
- Confirm Rx$855
- GREENLIGHT$558
- Barostim Neo System$433
- JOT DX$413
- GENERAL BPH$385
- Micra$295
- MERLIN@HOME$255
- BioMonitor$246
- OPTIMIZER$245
- Carto 3$228
- ENSITE PRECISION$184
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$181
How this compares
$48,701 in reported general payments places this provider in the 65th percentile of 80 clinical cardiac electrophysiology providers in Arizona.
See all clinical cardiac electrophysiology providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MultaqDronedarone Hcl | 26 | $30,047 |
| XareltoRivaroxaban | 21 | $15,331 |
| EliquisApixaban | 14 | $8,612 |
| Mexiletine Hcl | 22 | $2,183 |
| Amiodarone Hcl | 56 | $1,517 |
| Metoprolol Succinate | 53 | $682 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $490 |
| Digoxin | 15 | $154 |
| Cephalexin | 14 | $83 |
| Metoprolol Tartrate | 15 | $80 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sanofi-aventis U.S. LLCMultaq | $292 | $30,04726 claims |
| Johnson & JohnsonXarelto | $416 | $15,33121 claims |
| PfizerEliquis | $22 | $8,61214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 80 clinical cardiac electrophysiology providers in Arizona.
Other clinical cardiac electrophysiology in Glendale
- Imran SheikhGlendale$15K
- Akash MakkarPhoenix$318K
- Jonathan WeissPhoenix$290K
- Ashish SadhuScottsdale$264K
- Yoaav KrauthammerPhoenix$238K
- Vijendra SwarupPhoenix$187K
- Paul HaasPhoenix$136K
- Andy TranSurprise$125K
- Ambrose PanicoMesa$108K
- Aadhavi SridharanTucson$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.